It's "tremendously unfair" yet in court it's an effective criticism of the FDA that it is undermanned and sometimes comes up short of fulfilling its mission. But "the amazing thing is how well FDA responds to the challenge" of being asked to do more with less money, writes Jim Beck in The Drug and Device Law blog. The agency faces globalization of food and drug regulation and is seeking harmonization with regulators around the world; it's also scrutinizing importers and moving to risk-based inspections and enforcement. Blog